NYSE$RDY
Dr. Reddys Laboratories Limited · Q3 2025 earnings
Q3 2025 earnings · · Investor relations
Briefing
RDY Q3 2025 — INR 2.00B revenue, 1.00 EPS
During the years ended March 31, 2024 and 2023, an aggregate of 81,353 and 49,295 equity shares, respectively were issued as a result of the exercise of vested options granted to employees pursuant to. Dr. Reddys Laboratories Limited reported Q3 2025 results. Diluted EPS came in at 1.00. Headline numbers extracted from the Form 20-F press release; narrative is light because this row was processed without an LLM call.
- Revenue: INR 2.00B.
- Diluted EPS: 1.00.
- Gross profit: INR 2.
Headline financials
Revenue & EPS history
Dr. Reddy's · Revenue · Quarterly
$977M
Revenue by segment
Dr. Reddy's · $79.5B total across 5 segments · Q4 2027
- North America Generics$23.6B—29.6%
- Emerging Markets$18.1B—22.7%
- India$15.7B—19.7%
- Europe$12.8B—16.0%
- PSAI (Active Pharmaceutical Ingredients)$9.48B—11.9%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2025
-1.1%
Avg return
Earnings day
-0.7%
Avg return
5 days after
-1.7%
Avg return
30 days after
40%
18 / 45 earnings
Positive
+9.9%
Q1 2021
Best reaction
-15.9%
Q1 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2027 | — | — | — | |
| Q1 2026 | — | — | — | |
| Q4 2027 | -2.2% | +0.0% | -3.4% | |
| Q2 2026 | -0.1% | -0.8% | -3.9% | |
| Q3 2025 | -7.2% | -10.3% | -11.5% | |
| Q1 2024 | +3.1% | +0.5% | -1.1% | |
| Q4 2023 | -9.3% | +0.8% | +14.1% | |
| Q2 2023 | -0.5% | +0.0% | +3.1% | |
| Q1 2023 | -5.3% | -5.6% | -4.3% | |
| Q4 2022 | +7.2% | +8.0% | +3.6% | |
| Q2 2022 | +4.1% | +5.9% | +0.4% | |
| Q3 2022 | +3.9% | +5.9% | +0.4% | |
| Q1 2022 | -12.9% | -13.9% | -17.1% | |
| Q4 2021 | -0.8% | -0.3% | -13.4% | |
| Q3 2021 | -10.4% | -5.2% | -9.2% | |
| Q2 2021 | -2.6% | -3.1% | -3.9% | |
| Q1 2021 | +9.9% | +1.0% | -2.2% | |
| Q4 2020 | +3.9% | +7.0% | +18.1% | |
| Q3 2020 | +6.0% | +4.0% | +2.6% | |
| Q2 2020 | +0.4% | +2.9% | +4.0% | |
| Q1 2020 | -5.9% | +0.4% | +8.5% | |
| Q4 2019 | -7.7% | -0.9% | -4.9% | |
| Q2 2019 | +3.8% | +3.1% | -1.3% | |
| Q3 2019 | +3.9% | +3.1% | -1.3% | |
| Q1 2019 | +0.0% | +2.7% | +15.0% | |
| Q4 2018 | -0.5% | +0.5% | +18.3% | |
| Q3 2018 | -2.8% | -9.9% | -14.8% | |
| Q2 2018 | -1.4% | +1.7% | -3.1% | |
| Q1 2018 | -11.6% | -10.4% | -23.9% | |
| Q4 2017 | +4.7% | +3.2% | +1.2% | |
| Q3 2017 | -1.6% | -3.3% | -8.4% | |
| Q2 2017 | +4.9% | +7.2% | -1.6% | |
| Q1 2017 | -15.9% | -16.2% | -12.3% | |
| Q4 2016 | +1.3% | — | — | |
| Q3 2016 | -6.5% | — | — | |
| Q2 2016 | +2.9% | — | — | |
| Q1 2016 | +9.9% | — | — | |
| Q4 2015 | +3.0% | — | — | |
| Q3 2015 | -3.8% | — | — | |
| Q2 2015 | +0.5% | — | — | |
| Q1 2015 | -1.5% | — | — | |
| Q4 2014 | -9.5% | — | — | |
| Q3 2013 | -1.0% | — | — | |
| Q2 2013 | -2.2% | — | — | |
| Q1 2013 | -1.7% | — | — | |
| Q4 2013 | -0.4% | — | — | |
| Q1 2010 | +1.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro